TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / Ordinary Shares, par value NIS 0.10 per share
Symbol
TEVA on NYSE
Shares outstanding
1,147,663,152
Price per share
$31.21
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
657,080,757
Total reported value
$13,259,436,344
% of total 13F portfolios
0.02%
Share change
-55,413,084
Value change
-$1,080,000,249
Avg buy value change
+0%
Avg sell value change
-0.01%
Number of holders
538
Price from insider filings
$30.20
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MENORA MIVTACHIM HOLDINGS LTD. 5% $1,003,267,624 57,395,173 Menora Mivtachim Holdings Ltd 16 Jul 2025
Phoenix Financial Ltd. 5% $1,003,057,595 57,383,158 Phoenix Financial Ltd. 14 Jul 2025
As of 30 Sep 2025, TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) has 538 institutional shareholders filing 13F forms. They hold 657,080,757 shares. of 1,147,663,152 outstanding shares (57%) .

Top 25 institutional shareholders own 41% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 5% 57,802,408 +6.4% 0.02% $1,167,608,637
Phoenix Financial Ltd. 3.6% 41,295,244 +9.4% 10% $834,163,929
MENORA MIVTACHIM HOLDINGS LTD. 3.4% 38,920,294 +1.1% 4% $786,189,939
Harel Insurance Investments & Financial Services Ltd. 3.3% 37,696,690 +13% 6.8% $761,455,000
Migdal Insurance & Financial Holdings Ltd. 2.8% 32,582,212 +14% 7.1% $658,161,000
Clal Insurance Enterprises Holdings Ltd 2.7% 31,486,683 -2.7% 4.8% $633,456,000
Lingotto Investment Management LLP 2.5% 28,588,790 +1.5% 11% $577,493,558
Rubric Capital Management LP 2.1% 24,650,000 -5.2% 6.7% $497,930,000
FMR LLC 2.1% 24,641,362 -58% 0.03% $497,755,500
PointState Capital LP 1.8% 20,712,398 0% 7.5% $418,390,440
STATE STREET CORP 1.5% 17,150,251 -0.79% 0.01% $346,435,070
GLENVIEW CAPITAL MANAGEMENT, LLC 1.5% 16,692,680 +5.5% 8.2% $337,192,136
Duquesne Family Office LLC 1.4% 16,593,935 +3.9% 8.5% $335,197,000
GEODE CAPITAL MANAGEMENT, LLC 0.87% 9,989,875 +3.7% 0.01% $200,476,496
Assenagon Asset Management S.A. 0.73% 8,328,356 -1.4% 0.25% $168,232,791
Altshuler Shaham Ltd 0.72% 8,297,424 +871% 2.7% $162,088,980
Slate Path Capital LP 0.69% 7,927,998 -4.4% 2.5% $160,145,560
BANK OF AMERICA CORP /DE/ 0.66% 7,562,443 -16% 0.01% $152,761,341
WELLINGTON MANAGEMENT GROUP LLP 0.6% 6,895,838 +39228% 0.02% $139,295,928
MORGAN STANLEY 0.56% 6,475,018 -2.1% 0.01% $130,795,411
Alyeska Investment Group, L.P. 0.52% 5,976,035 +146% 0.37% $120,715,907
Sound Shore Management Inc /CT/ 0.49% 5,647,449 -3.4% 3.8% $114,078,470
UBS Group AG 0.49% 5,614,080 +8.9% 0.02% $113,404,408
NORTHERN TRUST CORP 0.48% 5,519,279 +1.2% 0.01% $111,489,436
Ion Asset Management Ltd. 0.48% 5,510,000 -86% 14% $111,302,000

Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 3,436,325 $106,458,810 -$183,910,116 3,121.01% 23
2025 Q3 657,080,757 $13,259,436,344 -$1,080,000,249 2,020% 538
2025 Q2 712,590,449 $11,941,932,547 +$36,824,115 1,676% 533
2025 Q1 711,362,006 $10,926,436,536 +$519,129,639 1,537% 551
2024 Q4 665,517,753 $14,667,322,249 +$850,751,955 2,204% 568
2024 Q3 619,273,780 $11,154,568,623 +$273,381,127 1,802% 537
2024 Q2 608,938,268 $9,893,752,500 +$636,329,276 1,625% 527
2024 Q1 571,163,077 $8,054,591,803 -$17,524,572 1,411% 477
2023 Q4 351,378 $3,668,412 -$1,833,726 1,044% 5
2023 Q3 552,621,317 $5,636,174,609 +$724,238,731 1,020% 419
2023 Q2 483,174,345 $3,640,448,315 -$709,082,661 753% 410
2023 Q1 552,415,005 $4,882,717,793 -$28,452,555 885% 421
2022 Q4 544,933,380 $4,968,611,785 +$2,422,940 912% 405
2022 Q3 558,617,192 $4,501,147,777 +$430,391,642 806.99% 384
2022 Q2 493,037,296 $3,705,698,809 -$46,278,063 752% 414
2022 Q1 507,252,222 $4,763,039,652 +$104,021,625 939% 412
2021 Q4 496,328,229 $3,973,307,201 -$264,080,714 800.99% 393
2021 Q3 519,494,143 $5,059,454,033 -$346,038,930 974.01% 404
2021 Q2 555,826,183 $5,503,173,470 -$133,814,474 990% 418
2021 Q1 567,815,199 $6,552,368,211 +$15,087,998 1,153.98% 427
2020 Q4 558,289,864 $5,377,223,368 +$54,391,696 965% 410
2020 Q3 562,001,358 $5,058,190,412 -$193,039,448 900.99% 412
2020 Q2 563,150,219 $6,934,500,828 +$316,246,771 1,233% 425
2020 Q1 549,380,727 $4,930,621,214 -$447,758,611 898% 423
2019 Q4 583,357,497 $5,716,381,171 -$12,628,622 980% 392
2019 Q3 583,951,173 $4,016,000,487 -$352,198,112 688% 373
2019 Q2 634,679,467 $5,855,115,632 -$327,176,170 923% 428
2019 Q1 666,526,116 $10,448,699,049 -$208,438,618 1,567.99% 488
2018 Q4 678,695,583 $10,469,349,002 +$638,670,462 1,542% 512
2018 Q3 635,796,253 $13,694,092,715 -$673,378,875 2,153.98% 539
2018 Q2 666,522,359 $16,210,057,077 +$160,229,711 2,431.99% 520
2018 Q1 663,951,724 $11,346,647,210 +$1,296,159,719 1,709% 487
2017 Q4 583,006,019 $11,047,093,789 +$1,031,512,489 1,895% 485
2017 Q3 530,793,870 $9,338,408,413 -$1,109,533,807 1,760% 511
2017 Q2 585,810,513 $19,441,260,732 +$409,792,203 3,321.99% 638
2017 Q1 574,529,023 $18,441,355,439 +$208,558,245 3,209% 677
2016 Q4 594,707,762 $21,556,505,638 +$595,483,573 3,625% 718
2016 Q3 567,362,612 $26,075,006,560 -$1,241,530,082 4,600.99% 782
2016 Q2 595,195,959 $29,897,915,811 -$269,521,838 5,023% 800
2016 Q1 596,465,578 $31,927,539,469 -$699,029,161 5,351% 825
2015 Q4 609,577,849 $40,010,073,356 +$4,895,540,689 6,563.99% 866
2015 Q3 519,485,533 $29,335,153,511 +$628,822,684 5,646% 805
2015 Q2 512,409,549 $30,278,712,384 -$366,660,797 5,910% 807
2015 Q1 522,126,620 $32,520,072,766 +$494,030,657 6,230% 815
2014 Q4 517,348,570 $29,742,656,502 +$654,033,289 5,750.99% 811
2014 Q3 499,756,458 $26,847,989,386 +$670,006,833 5,375% 761
2014 Q2 486,823,544 $25,524,251,027 +$774,424,647 5,242% 768
2014 Q1 472,067,564 $24,920,431,379 +$989,421,387 5,284% 762